相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Observation of an unusual electronically distorted semiquinone radical of PCB metabolites in the active site of prostaglandin H synthase-2
Orarat Wangpradit et al.
CHEMOSPHERE (2010)
Cyclooxygenase and Neuroinflammation in Parkinson's Disease Neurodegeneration
Anna L. Bartels et al.
CURRENT NEUROPHARMACOLOGY (2010)
Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide
Yang Song et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
The Role of Oxidative Stress in Amyotrophic Lateral Sclerosis and Parkinson's Disease
Athan Baillet et al.
NEUROCHEMICAL RESEARCH (2010)
An aggregate-prone mutant of human glyceraldehyde-3-phosphate dehydrogenase augments oxidative stress-induced cell death in SH-SY5Y cells
Hidemitsu Nakajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Oxidation of 4-Chlorobiphenyl Metabolites to Electrophilic Species by Prostaglandin H Synthase
Orarat Wangpradit et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Prostaglandin H Synthase-1-Catalyzed Bioactivation of Neurotransmitters, Their Precursors, and Metabolites: Oxidative DNA Damage and Electron Spin Resonance Spectroscopy Studies
Luisa L. Goncalves et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive Intermediate
Yunden Jinsmaa et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Glyceraldehyde-3-phosphate Dehydrogenase Aggregate Formation Participates in Oxidative Stress-induced Cell Death
Hidemitsu Nakajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Redox imbalance in Parkinson's disease
Shankar J. Chinta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
A review of Parkinson's disease
C. A. Davie
BRITISH MEDICAL BULLETIN (2008)
Semiquinone radicals from oxygenated polychlorinated biphenyls: Electron paramagnetic resonance studies
Yang Song et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Cyclooxygenase-2 is involved in oxidative damage and alpha-synuclein accumulation in dopaminergic cells
Sung-Wook Chae et al.
NEUROSCIENCE LETTERS (2008)
Lipid peroxidation products inhibit dopamine catabolism yielding aberrant levels of a reactive intermediate
Jennifer N. Rees et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death
Hidemitsu Nakajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: The role of aldehyde dehydrogenase
Satori A. Marchitti et al.
PHARMACOLOGICAL REVIEWS (2007)
Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system
Randy L. Hunter et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Metal-catalyzed oxidation of protein-bound dopamine
Mitsugu Akagawa et al.
BIOCHEMISTRY (2006)
One-electron oxidation of catecholamines generates free radicals with an in vitro toxicity correlating with their lifetime
Ole Terland et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease
Rattanavijit Vijitruth et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Dopamine covalently modifies and functionally inactivates parkin
MJ LaVoie et al.
NATURE MEDICINE (2005)
Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases
L Minghetti
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Catecholamine metabolism: A contemporary view with implications for physiology and medicine
G Eisenhofer et al.
PHARMACOLOGICAL REVIEWS (2004)
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases
WJ Burke et al.
NEUROTOXICOLOGY (2004)
Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases
M Asanuma et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
3,4-dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis
WJ Burke et al.
BRAIN RESEARCH (2003)
COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice
ZH Feng et al.
NEUROREPORT (2003)
3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinson's Disease
W. J. Burke
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
Potential neurotoxic agents provocateurs in Parkinson's disease
MA Collins et al.
NEUROTOXICOLOGY AND TERATOLOGY (2002)
Oxidative metabolite of dopamine, 3,4-dihydroxyphenylacetaldehyde, induces dopamine release from PC12 cells by a Ca2+-independent mechanism
T Hashimoto et al.
BRAIN RESEARCH (2002)
3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis
SW Li et al.
MOLECULAR BRAIN RESEARCH (2001)
Electron paramagnetic resonance study on free radical scavenging and/or generating activity of dopamine-4-O-sulfate
K Kirima et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2001)
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria
BS Kristal et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells
I Lamensdorf et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
